Orphenadrine Citrate(CAS: 4596-23-0)

Orphenadrine Citrate (CAS: 4596-23-0) is regulated under the Chemicals of the Classification, Labelling, and Packaging Regulation (CLP) in the European Union. In the United States, it falls under the jurisdiction of the Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA). Compliance with REACH regulations is also required for its import and use in the EU. Proper labeling and safety data sheets are essential for handling and storage.

Alternatives to Orphenadrine Citrate (CAS: 4596-23-0) in synthesis include similar anticholinergic compounds like Procaine and Propantheline Bromide. For synthetic routes, isomers and analogs such as orphenadrine hydrochloride can be considered. Substitutes like benztropine mesylate and trihexyphenidyl hydrochloride can be explored based on specific needs and regulatory considerations.

The market for Orphenadrine Citrate (CAS: 4596-23-0) is primarily focused on its use as an antispasmodic and anticholinergic agent. Research trends include exploring its potential in treating muscarinic receptor-mediated conditions. Demand is stable, with ongoing studies into its therapeutic applications and safety profiles. Price trends are influenced by regulatory changes and supply chain dynamics.

Waste containing Orphenadrine Citrate (CAS: 4596-23-0) should be collected in appropriate containers labeled with the chemical name and hazard information. It should be disposed of through a professional waste management service that can handle hazardous chemicals. Environmental protection precautions include ensuring proper containment to prevent leakage and following local regulations for disposal.